Roivant Sciences, Pharvaris, IonQ And Other Big Stocks Moving Higher On Tuesday
U.S. stocks fell Tuesday, but Roivant surged 16% on positive PH-ILD trial data. Pharvaris, Solaris, IonQ and quantum stocks also posted strong gains.
Stocks · News reference
IonQ Raises FY2026 Sales Guidance from $280.000M-$290.000M to $450.000M-$460.000M
IonQ (NYSE:IONQ) raises FY2026 sales outlook from $280.000 million-$290.000 million to $450.000 million-$460.000 million. This outlook includes the contributions of SkyWater Technology beginning on July 31, 2026, the
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
IonQ Raises 2026 Outlook After SkyWater Deal
IonQ raises its full-year 2026 revenue guidance to $450M-$460M following its acquisition of SkyWater Technology. Read the full update.
IonQ shares are trading higher after the company announced it published the first complete, end-to-end fault-tolerant resource estimate for running Shor’s algorithm.
IonQ Says Research Paper Estimates 20,000-Physical-Qubit Quantum Computer Could Break Bitcoin's secp256k1 Elliptic Curve In Just Under 26 Days; Says On Track For Fault-Tolerant 10,000-Qubit System In 2027